Search research articles
Contact Us
Filters
Showing results (171-180 of 186) with videos related to
Page
of 19
Sort By:
Molecular Cancer Therapeutics
|
July 25, 2022
Comparative Oncology Assessment of a Novel Inhibitor of Valosin-Containing Protein in Tumor-Bearing Dogs
Amy K LeBlanc, Christina N Mazcko, Timothy M Fan, et al.
Radiology
|
March 25, 2016
Colorectal Cancer Liver Metastases: Biopsy of the Ablation Zone and Margins Can Be Used to Predict Oncologic Outcome
Vlasios S Sotirchos, Lydia M Petrovic, Mithat Gönen, et al.
Cancer Chemotherapy and Pharmacology
|
May 13, 2016
Clinical and pharmacologic evaluation of two dosing schedules of indotecan (LMP400), a novel indenoisoquinoline, in patients with advanced solid tumors
Shivaani Kummar, Alice Chen, Martin Gutierrez, et al.
Cancers
|
February 15, 2022
Biopsy and Margins Optimize Outcomes after Thermal Ablation of Colorectal Liver Metastases
Nikiforos Vasiniotis Kamarinos, Efsevia Vakiani, Mithat Gonen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 3, 2016
Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone
Karen T Brown, Richard K Do, Mithat Gonen, et al.
Radiology
|
November 28, 2018
Autologous Blood Patch Injection versus Hydrogel Plug in CT-guided Lung Biopsy: A Prospective Randomized Trial
Majid Maybody, Nadim Muallem, Karen T Brown, et al.
Cancer Chemotherapy and Pharmacology
|
December 22, 2025
A phase 1 study of orally administered 5-fluoro-2'-deoxycytidine with tetrahydrouridine in patients with refractory solid tumors
Alice P Chen, Shivaani Kummar, Larry Rubinstein, et al.
Cancer Chemotherapy and Pharmacology
|
April 22, 2020
Intravenous 5-fluoro-2'-deoxycytidine administered with tetrahydrouridine increases the proportion of p16-expressing circulating tumor cells in patients with advanced solid tumors
Geraldine O 'Sullivan Coyne, Lihua Wang, Jennifer Zlott, et al.
Oncotarget
|
March 4, 2021
Phase 1 study of Z-endoxifen in patients with advanced gynecologic, desmoid, and hormone receptor-positive solid tumors
Naoko Takebe, Geraldine O'Sullivan Coyne, Shivaani Kummar, et al.
Journal of Cellular Biochemistry. Supplement
|
January 1, 1996
Strategy and planning for chemopreventive drug development: clinical development plans II
G J Kelloff, J A Crowell, E T Hawk, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 186) with videos related to
Sort By:
Page
of 19
Molecular Cancer Therapeutics
|
July 25, 2022
Comparative Oncology Assessment of a Novel Inhibitor of Valosin-Containing Protein in Tumor-Bearing Dogs
Amy K LeBlanc, Christina N Mazcko, Timothy M Fan, et al.
Radiology
|
March 25, 2016
Colorectal Cancer Liver Metastases: Biopsy of the Ablation Zone and Margins Can Be Used to Predict Oncologic Outcome
Vlasios S Sotirchos, Lydia M Petrovic, Mithat Gönen, et al.
Cancer Chemotherapy and Pharmacology
|
May 13, 2016
Clinical and pharmacologic evaluation of two dosing schedules of indotecan (LMP400), a novel indenoisoquinoline, in patients with advanced solid tumors
Shivaani Kummar, Alice Chen, Martin Gutierrez, et al.
Cancers
|
February 15, 2022
Biopsy and Margins Optimize Outcomes after Thermal Ablation of Colorectal Liver Metastases
Nikiforos Vasiniotis Kamarinos, Efsevia Vakiani, Mithat Gonen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 3, 2016
Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone
Karen T Brown, Richard K Do, Mithat Gonen, et al.
Radiology
|
November 28, 2018
Autologous Blood Patch Injection versus Hydrogel Plug in CT-guided Lung Biopsy: A Prospective Randomized Trial
Majid Maybody, Nadim Muallem, Karen T Brown, et al.
Cancer Chemotherapy and Pharmacology
|
December 22, 2025
A phase 1 study of orally administered 5-fluoro-2'-deoxycytidine with tetrahydrouridine in patients with refractory solid tumors
Alice P Chen, Shivaani Kummar, Larry Rubinstein, et al.
Cancer Chemotherapy and Pharmacology
|
April 22, 2020
Intravenous 5-fluoro-2'-deoxycytidine administered with tetrahydrouridine increases the proportion of p16-expressing circulating tumor cells in patients with advanced solid tumors
Geraldine O 'Sullivan Coyne, Lihua Wang, Jennifer Zlott, et al.
Oncotarget
|
March 4, 2021
Phase 1 study of Z-endoxifen in patients with advanced gynecologic, desmoid, and hormone receptor-positive solid tumors
Naoko Takebe, Geraldine O'Sullivan Coyne, Shivaani Kummar, et al.
Journal of Cellular Biochemistry. Supplement
|
January 1, 1996
Strategy and planning for chemopreventive drug development: clinical development plans II
G J Kelloff, J A Crowell, E T Hawk, et al.
Page
of 19